These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35566617)

  • 1. General Purpose Pharmacokinetic-Pharmacodynamic Models for Target-Controlled Infusion of Anaesthetic Drugs: A Narrative Review.
    Vandemoortele O; Hannivoort LN; Vanhoorebeeck F; Struys MMRF; Vereecke HEM
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
    Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
    Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pharmacokinetics and pharmacodynamics in clinical anaesthesia practice.
    Hannivoort LN; Absalom AR; Struys MMRF
    Curr Opin Anaesthesiol; 2020 Aug; 33(4):483-489. PubMed ID: 32530894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
    Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
    Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetic-Pharmacodynamic Modeling for Propofol Anesthesia Guided by the Bispectral Index (BIS).
    Araújo AM; Machado H; de Pinho PG; Soares-da-Silva P; Falcão A
    J Clin Pharmacol; 2020 May; 60(5):617-628. PubMed ID: 31797395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol pharmacokinetic and pharmacodynamic profile and its electroencephalographic interaction with remifentanil in children.
    Fuentes R; Cortínez LI; Contreras V; Ibacache M; Anderson BJ
    Paediatr Anaesth; 2018 Dec; 28(12):1078-1086. PubMed ID: 30307663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in pharmacokinetic modeling: target controlled infusions in the obese.
    Cortínez LI; Anderson BJ
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):415-422. PubMed ID: 29794852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and anesthetic pharmacology: simulation of target-controlled infusion models of propofol and remifentanil.
    Kim TK
    Korean J Anesthesiol; 2021 Dec; 74(6):478-487. PubMed ID: 34407372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
    Eleveld DJ; Colin P; Absalom AR; Struys MMRF
    Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on propofol TCI in children].
    Constant I; Rigouzzo A; Louvet N
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):e37-42. PubMed ID: 23219572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic population modelling in paediatric anaesthesia and its clinical translation.
    Morse JD; Hannam J; Anderson BJ
    Curr Opin Anaesthesiol; 2019 Jun; 32(3):353-362. PubMed ID: 31045640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
    Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
    Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which model for propofol TCI in children.
    Constant I; Rigouzzo A
    Paediatr Anaesth; 2010 Mar; 20(3):233-9. PubMed ID: 20470319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations for Intravenous Anesthesia Dose in Obese Children: Understanding PKPD.
    Morse JD; Cortinez LI; Anderson BJ
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
    Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
    Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.
    Minto CF; Schnider TW; Shafer SL
    Anesthesiology; 1997 Jan; 86(1):24-33. PubMed ID: 9009936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.
    Coetzee JF
    Clin Pharmacokinet; 2012 Mar; 51(3):137-45. PubMed ID: 22316280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients.
    Al-Sallami H; Newall F; Monagle P; Ignjatovic V; Cranswick N; Duffull S
    Br J Clin Pharmacol; 2016 Jul; 82(1):178-84. PubMed ID: 26972703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail.
    Absalom AR; Mani V; De Smet T; Struys MM
    Br J Anaesth; 2009 Jul; 103(1):26-37. PubMed ID: 19520702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational mixed-effects PKPD modelling of recombinant human growth hormone - from hypophysectomized rat to patients.
    Thorsted A; Thygesen P; Agersø H; Laursen T; Kreilgaard M
    Br J Pharmacol; 2016 Jun; 173(11):1742-55. PubMed ID: 26921845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.